Recently, new reports tried to assess the existence of any correlation between mutations in the main genes (BRAF/NRAS) involved in melanoma initiation and progression (23); they have proposed a distinct molecular classification for MUP to explain the differences in patient outcomes. The gene discussed is BRAF; the disease is melanoma.